Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: EC:3.1.3.16 (
calcineurin
)
17,112
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
It is thought that the nuclear nonchromatin structures, such as the nuclear matrix and lamina, play regulatory roles in gene expression. In this study, we identified an insoluble protein that was associated with the chromatin-depleted nuclear structure of proliferating human leukemia HL-60 cells. Preparation of the chromatin-depleted nuclear structure, referred to as the nuclear matrix-intermediate filament scaffold (Fey, E., Krochmalnic, G., and Penman, S. (1986) J. Cell. Biol. 102, 1654-1665), involved cell extraction using a series of buffers containing Triton X-100, DNase I, and 2 M NaCl. A yeast two-hybrid assay revealed that this protein bound to the catalytic subunit of
protein phosphatase-1
(PP1). Furthermore, it inhibited PP1 activity in vitro. We therefore named it
scapinin
(
scaffold-associated PP1 inhibiting protein
). cDNA cloning revealed that
scapinin
had two splicing variants of 448 amino acids (scapinin-S) and 518 amino acids (scapinin-L).
Scapinin
was down-regulated by differentiation in HL-60 cells. These results suggest that
scapinin
is a putative regulatory subunit of PP1 and is involved in transformed or immature phenotypes of HL-60 cells. We also describe the presence of
scapinin
family proteins from worm to human.
...
PMID:Scapinin, a putative protein phosphatase-1 regulatory subunit associated with the nuclear nonchromatin structure. 1292 32
Scapinin
has been found to bind to cytoplasmic actin and is also a putative regulatory subunit of
protein phosphatase-1
(PP1). It is found attached to the nuclear matrix-intermediate filament (NM-IF) and is down-regulated by differentiation of tumor cells. We have analyzed the genomic structure and tissue-specific expression pattern of both the human
scapinin
gene (PHACTR3) and the orthologous mouse gene. Both genes showed a highly conserved complex genomic organization with four different leader exons. Alternative splicing of exon 5 was found to be limited to human and variable polyadenylation in mouse transcripts only. In both species expression seems to occur predominantly in the brain. By Northern blot analysis two major transcripts in human and three transcripts in mouse were detected. Expression analysis in the mouse revealed a tissue-specific complex transcription pattern in the brain and a specific pattern was observed during prenatal development. Based on the transcriptional data we therefore assume
scapinin
to have a distinct biological function in the mammalian brain.
...
PMID:Genomic organization and expression pattern of scapinin (PHACTR3) in mouse and human. 1697 80
Scapinin
, also named phactr3, is an actin and
protein phosphatase
1 (PP1) binding protein, which is expressed in the adult brain and some tumor cells. At present, the role(s) of
scapinin
in the brain and tumors are poorly understood. We show that the RPEL-repeat domain of
scapinin
, which is responsible for its direct interaction with actin, inhibits actin polymerization in vitro. Next, we established a Hela cell line, where
scapinin
expression was induced by tetracycline. In these cells, expression of
scapinin
stimulated cell spreading and motility.
Scapinin
was colocalized with actin at the edge of spreading cells. To explore the roles of the RPEL-repeat and PP1-binding domains, we expressed wild-type and mutant scapinins as fusion proteins with green fluorescence protein (GFP) in Cos7 cells. Expression of GFP-
scapinin
(wild type) also stimulated cell spreading, but mutation in the RPEL-repeat domain abolished both the actin binding and the cell spreading activity. PP1-binding deficient mutants strongly induced cell retraction. Long and branched cytoplasmic processes were developed during the cell retraction. These results suggest that
scapinin
enhances cell spreading and motility through direct interaction with actin and that PP1 plays a regulatory role in
scapinin
-induced morphological changes.
...
PMID:Scapinin, the protein phosphatase 1 binding protein, enhances cell spreading and motility by interacting with the actin cytoskeleton. 1915 53
Proteins that belong to the
protein phosphatase
1 and actin regulator (phactr) family are involved in cell motility and morphogenesis. However, the mechanisms that regulate the actin cytoskeleton are poorly understood. We have previously shown that phactr3, also known as
scapinin
, localizes to the plasma membrane, including lamellipodia and membrane ruffles. In the present study, experiments using deletion and point mutants showed that the basic and hydrophobic residues in the N-terminus play crucial roles in the localization to the plasma membrane. A BH analysis (http://helixweb.nih.gov/bhsearch) is a program developed to identify membrane-binding domains that comprise basic and hydrophobic residues in membrane proteins. We applied this program to phactr3. The results of the BH plot analysis agreed with the experimentally determined region that is responsible for the localization of phactr3 to the plasma membrane. In vitro experiments showed that the N-terminal itself binds to liposomes and acidic phospholipids. In addition, we showed that the interaction with the plasma membrane via the N-terminal membrane-binding sequence is required for phactr3-induced morphological changes in Cos7 cells. The membrane-binding sequence in the N-terminus is highly conserved in all members of the phactr family. Our findings may provide a molecular basis for understanding the mechanisms that allow phactr proteins to regulate cell morphogenesis.
...
PMID:Phactr3/scapinin, a member of protein phosphatase 1 and actin regulator (phactr) family, interacts with the plasma membrane via basic and hydrophobic residues in the N-terminus. 2540 72
Phosphatase and actin regulator 3/nuclear scaffold-associated
protein phosphatase
1-inhibiting protein (Phactr3/
Scapinin
) is an actin- and
protein phosphatase
1 (PP1)-binding protein known to negatively regulate axon elongation. In this study, we examined the expression pattern of Phactr3/
Scapinin
in several tissues and investigated the effect of Phactr3/
Scapinin
on dendritic morphology of cortical neurons. Results showed that Phactr3/
Scapinin
expression was up-regulated in the developing brain and enriched in neurons and in the postsynaptic density fraction, but not in astrocytes. Overexpression of wild type or mutant Phactr3/
Scapinin
, which lacked actin-binding activity, resulted in increased dendritic complexity and percentage of spines with a mushroom or stubby shape, as well as a decrease in spine density. However, overexpression of mutant Phactr3/
Scapinin
that lacked PP1-binding activity did not. Taken together, these findings suggest that Phactr3/
Scapinin
expression is neuronal and might contribute to synaptic formation via distinct actin- and PP1-binding domains involved in dendritic and axonal morphology, respectively.
...
PMID:Neuron-enriched phosphatase and actin regulator 3 (Phactr3)/ nuclear scaffold-associated PP1-inhibiting protein (Scapinin) regulates dendritic morphology via its protein phosphatase 1-binding domain. 3242 95